Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cong Dai

Showing results (61-70 of 270) with videos related to

Pageof 27
Sort By:
Gastroenterology|April 5, 2017
Rifaximin in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel SyndromeCong Dai, Min Jiang, Ming-Jun Sun
Annals of Translational Medicine|March 28, 2015
Innate immunity and adaptive immunity in Crohn's diseaseCong Dai, Min Jiang, Ming-Jun Sun
World Journal of Gastroenterology|May 1, 2024
Fecal microbiota transplantation for irritable bowel syndrome: Current evidence and perspectivesCong Dai, Yu-Hong Huang, Min Jiang
The American Journal of Gastroenterology|December 27, 2024
Visual Endoscopic Retrograde Appendicitis Therapy vs Antibiotic Therapy for Treatment of Uncomplicated Acute AppendicitisCong Dai, Yu-Hong Huang, Min Jiang
International Journal of Molecular Medicine|November 18, 2011
VSL#3 probiotics regulate the intestinal epithelial barrier in vivo and in vitro via the p38 and ERK signaling pathwaysCong Dai, De-Hui Zhao, Min Jiang
The American Journal of Gastroenterology|July 21, 2017
The Risk of Gallstone Disease Following Colectomy for Ulcerative ColitisCong Dai, Min Jiang, Ming-Jun Sun
Journal of Clinical Gastroenterology|September 17, 2019
Oral Nano Vitamin D Supplementation and Disease Activity in Ulcerative ColitisCong Dai, Min Jiang, Ming-Jun Sun
Digestive Diseases and Sciences|October 19, 2017
Fecal Calprotectin in Monitoring the Disease Activity in Colonic Inflammatory Bowel DiseaseCong Dai, Min Jiang, Ming-Jun Sun
Gastroenterology|November 28, 2017
Clostridium difficile Infection Among Individuals With Inflammatory Bowel DiseaseCong Dai, Min Jiang, Ming-Jun Sun
Journal of Crohn'S & Colitis|February 13, 2019
Long-Term Outcomes of Proactive Therapeutic Drug Monitoring of Adalimumab and Standard of Care in Patients With Inflammatory Bowel DiseaseCong Dai, Min Jiang, Ji-Hong Yu
Pageof 27

Showing results (61-70 of 270) with videos related to

Sort By:
Pageof 27
Gastroenterology|April 5, 2017
Rifaximin in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel SyndromeCong Dai, Min Jiang, Ming-Jun Sun
Annals of Translational Medicine|March 28, 2015
Innate immunity and adaptive immunity in Crohn's diseaseCong Dai, Min Jiang, Ming-Jun Sun
World Journal of Gastroenterology|May 1, 2024
Fecal microbiota transplantation for irritable bowel syndrome: Current evidence and perspectivesCong Dai, Yu-Hong Huang, Min Jiang
The American Journal of Gastroenterology|December 27, 2024
Visual Endoscopic Retrograde Appendicitis Therapy vs Antibiotic Therapy for Treatment of Uncomplicated Acute AppendicitisCong Dai, Yu-Hong Huang, Min Jiang
International Journal of Molecular Medicine|November 18, 2011
VSL#3 probiotics regulate the intestinal epithelial barrier in vivo and in vitro via the p38 and ERK signaling pathwaysCong Dai, De-Hui Zhao, Min Jiang
The American Journal of Gastroenterology|July 21, 2017
The Risk of Gallstone Disease Following Colectomy for Ulcerative ColitisCong Dai, Min Jiang, Ming-Jun Sun
Journal of Clinical Gastroenterology|September 17, 2019
Oral Nano Vitamin D Supplementation and Disease Activity in Ulcerative ColitisCong Dai, Min Jiang, Ming-Jun Sun
Digestive Diseases and Sciences|October 19, 2017
Fecal Calprotectin in Monitoring the Disease Activity in Colonic Inflammatory Bowel DiseaseCong Dai, Min Jiang, Ming-Jun Sun
Gastroenterology|November 28, 2017
Clostridium difficile Infection Among Individuals With Inflammatory Bowel DiseaseCong Dai, Min Jiang, Ming-Jun Sun
Journal of Crohn'S & Colitis|February 13, 2019
Long-Term Outcomes of Proactive Therapeutic Drug Monitoring of Adalimumab and Standard of Care in Patients With Inflammatory Bowel DiseaseCong Dai, Min Jiang, Ji-Hong Yu
Pageof 27